Publications
Selected Publications
Park JS*, Gazzaniga FS*, Wu M, Luthens AK, Gillis J, Zheng W, LaFleur MW, Johnson SB, Morad G, Park EM, Zhou Y, Watowich SS, Wargo JA, Freeman GJ**, Kasper DL**, Sharpe AH**. Targeting PD-L2–RGMb overcomes microbiome-related immunotherapy resistance. Nature. 617 377-385 (2023). [PMID 37138075]*These authors contributed equally to this work, ** These authors equally supervised this work.
Gazzaniga FS, Camacho DM, Wu M, Palazzo M, Dinis A, Grafton FN, Cartwright MJ, Super M, KasperDL, Ingber DE. Harnessing Colon Chip technology to identify commensal bacteria that promote host tolerance to infection. Front. Cell. Infect Microbiol. 11:638014 (2021). [PubMed 33777849].
Zheng W, Zhao W, Wu M, Song X, Caro F, Sun X, Gazzaniga F, Stefanetti G, Oh S, Mekalanos JJ, Kasper DL. Microbiota-targeted maternal antibodies protect neonates from enteric infection. Nature. 577(7791):543-548 (2020). [PubMed 31915378]
Jalili-Firoozinezhad S*, Gazzaniga FS*, Calamari EL*, Camacho DM, Fadel CW, Bein A, Swenor B, Nestor B, Cronce MJ, Tovaglieri A, Levy O, Gregory KE, Breault DT, Cabral JMS, Kasper DL, Novak R, Ingber DE. A Complex human gut microbiome cultured in an anaerobic intestine-on-a-chip. Nat Biomed Eng. 3(7):520-531 (2019). [PubMed 31086325]
*These authors contributed equally to this work
Erturk-Hasdemir D, Oh SF, Okan NA, Stefanetti G, Gazzaniga FS, Seeberger PH, Plevy SE, Kasper DL. Symbionts exploit complex signaling to educate the immune system. Proc Natl Acad Sci USA. 116(52)26157-26166 (2019). [PubMed 31811024]